课题基金 / 基金详情

PEMPHIGUS AS A MODEL ORGAN-SPECIFIC AUTOIMMUNE DISEASE

PEMPHIGUS AS A MODEL ORGAN-SPECIFIC AUTOIMMUNE DISEASE
天疱疮作为器官特异性自身免疫性疾病的模型
批准号:
6323916
负责人:
JEAN-CLAUDE BYSTRYN
金额:
$4.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-03 至 2001-05-05

项目摘要

项目成果

JEAN-CLAUDE BYSTRYN的其他基金

相关文献

中文摘要
翻译
描述(摘自申请人摘要):天疱疮的目的 会议将汇集从事基础免疫学研究的科学家 人类自身免疫方面和天疱疮研究工作。 由领先专家进行的关于自身免疫基础研究的演讲将 与介绍天疱疮研究交替进行。在最后一段,我们 将探讨人类自身免疫性疾病的新兴疗法, 疾病和天疱疮。科学家之间的想法交叉杂交,报告 人类自身免疫领域的新发展和新疗法将是 这次会议的目的。因为天疱疮是一个真正的例子, 器官特异性自身免疫性疾病,天疱疮会议将吸引 致力于研究和治疗这种疾病的科学家和临床医生。
英文摘要
DESCRIPTION (Taken from the applicant's abstract): The purpose of the Pemphigus Conference will be to bring together scientists working in basic immunological aspects of human autoimmunity and those working in pemphigus research. Presentations on basic research on autoimmunity by leading experts will alternate with presentations on pemphigus research. In the last segment, we will approach the subject of new emerging therapies in human autoimmune diseases and pemphigus. Cross-hybridization of ideas among scientists, report of new developments in the area of human autoimmunity and new therapies will be the aim of this conference. Since pemphigus is a true example of pathological organ-specific autoimmune disease, the Pemphigus Conference will attract scientists and clinicians dedicated to investigate and treat this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II RANDOMIZED TRIAL OF IVIG WITH OR WITHOUT CYCLOPHOSPHAMIDE IN PEMPHIGUS
SERUM CYT-MAA AS AN EARLY MARKER OF RESPONSE TO THERAPY IN RESECTED MELANOMA
PHASE II RANDOMIZED TRIAL OF IVIG WITH OR WITHOUT CYCLOPHOSPHAMIDE IN PEMPHIGUS
PEMPHIGUS 2005-PROGRESS AND FUTURE DIRECTIONS